Press Release: Milestone Quarter on the Path to Deliver Biochemicals at Scale
- Details
- Thursday, 27 May 2021
Oslo, 27 May 2021 — Circa Group AS (Euronext Growth Oslo: CIRCA) today announced its first quarter 2021 results. During the quarter, Circa raised more than EUR 50 million in equity financing and subsequently listed on Euronext Growth Oslo. Circa is now fully financed to construct the ReSolute™ plant in France, the 1,000 tonnes Levoglucosenone (LGO) and Cyrene™ production facility. The ReSolute™ project, which is led by Circa and comprised of 11 other partners, has continued to see strong regional and EU support.
13 May 2021 – DMC Biotechnologies has completed downstream processing for its first product, the amino acid L-alanine. The downstream processing was done at EW Biotech in Leuna, Germany following the successful demonstration of commercial scale fermentation at the same site in 
Oslo, Norway – 29 April 2021 — Circa Group AS (ticker code: CIRCA) today announced that Trond Stangeby and Greg Court have formally joined its Board of Directors. Together, they hold significant experience from industry, executive management, corporate governance and public listings.
Here we go again, Earth Day 🌍
